Boston Scientific's heart stent wins approval in Canada

04/26/2012 | Reuters

Boston Scientific has received approval from Health Canada for its PROMUS Element Plus stent and plans to start marketing the device there immediately. The device, designed to treat patients with coronary artery disease, improves on the company's existing stent with a better-performing catheter delivery system.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations